By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Drug Companies Need Evidence Generation Strategies
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Drug Companies Need Evidence Generation Strategies
Policy & Law

Drug Companies Need Evidence Generation Strategies

Aises Jammy
Aises Jammy
Share
5 Min Read
gather evidence on the effectiveness of new drugs
Shutterstock Photo License - Dmitry Kalinovsky
SHARE

The pharmaceutical industry has undergone some tremendous changes in recent years. Despite changes brought on by the Patient Protection and Affordable Care Act and other trends, it is still one of the largest industries in the United States and the rest of the world. The global market for pharmaceuticals is currently worth over $405 billion.

Contents
  • Drug Companies Need to Generate Evidence Proving the Quality of their Products
  • Evidence generation strategy – what is it
  • Why pharmaceutical companies need an evidence-gathering strategy
  • Key Elements of Strategic Research Planning
    • Evidence strategy development by consulting firms

Although there are a lot of opportunities as a drug manufacturer, there are also some challenges. Drug companies are under a lot of pressure to create the highest quality pharmaceuticals to meet the needs of their customers.

In order to achieve this goal, they have to get the evidence needed to prove the safety and efficacy of their products. Keep reading to learn how they can do this.

Drug Companies Need to Generate Evidence Proving the Quality of their Products

Every year the competition in the drug market is getting more challenging. This is one of the biggest trends shaping the industry. Each new drug they develop requires a comparative evaluation and proof of its effectiveness and economic value.

More Read

Bo
Healthcare Is Part of Our Supply Chain: The Boeing Company
Obama, Ryan and You
Addressing Mental Health Problems in America’s Schools
How the Cleveland Clinic Controls Health Care Costs
America Spends More on Emergency Medicine Than Previously Thought. Good or Bad?

At the same time, the evidence requirements are getting stricter. The FDA and other regulators require pharmaceutical companies to demonstrate the safety of their products, especially when there is so much controversy over things like the COVID-19 vaccines. For this reason, obtaining comprehensive evidence of the value of manufactured products has become critical in the pharmaceutical industry over the past few years. In addition, a strategic research approach contributes to an evidence base that can be shared with all stakeholders on time.

Evidence generation strategy – what is it

Developing new pharmaceuticals is a process of evidence generation that the following qualities can characterize:

  • a focus on the outcome defined by the producing company;
  • full use of available data;
  • the detailed design of all research work;
  • the systematicity and standardization of research.

The result of such work is the creation of a single database of evidence, which demonstrates the new pharmaceutical’s value to payers and decision-makers.

There is growing pressure to improve the quality of evidence as the drug industry changes. The necessary steps in developing an evidence strategy are:

  • collecting and analyzing existing data, market research, and identifying competitive issues to identify gaps in the existing evidence base;
  • establishing the key value of a new drug or technology;
  • identifying and prioritizing the evidence supporting the key value of the novelty; 
  • identifying the resources required to collect the data, establishing a timetable for the work;
  • creating a publication plan and a strategy for communicating the generated evidence base to stakeholders.

In other words, developing an evidence strategy comes down to comprehensive planning of the research work. The main objective of such planning is to structure and align the data collection process with specific strategic goals.

Why pharmaceutical companies need an evidence-gathering strategy

Such companies have a complex organizational structure due to pharmaceutical product development, manufacturing, and sales processes. This, in turn, makes data collection for the evidence base more difficult because the more complex an organization is, the more difficult it is to establish communication between its departments and employees.

Developing an evidence base strategy allows research to be organized more quickly. As a consequence, the process of generating, verifying, and communicating evidence to clients and decision-makers is also much faster. This, in turn, makes the decision-making processes for market admissions and monetary compensation happen as quickly as possible, which gives the company a competitive advantage.

Key Elements of Strategic Research Planning

Effective strategic planning for obtaining evidence on new drugs includes:

  • top-level scientific expertise (both therapeutic and methodological);
  • A consistent approach;
  • Recommendations for developing an evidence base that is solution-oriented and communication-oriented;
  • emphasis on obtaining the evidence needed for a particular audience.

Drug company executives appreciate the need to do these things as rigorously as possible.

Evidence strategy development by consulting firms

Today, many consulting companies like digitalho offer evidence strategy development services. For this purpose, they use modern digital solutions that allow them to work with large amounts of information and new data types. The result of a competent development of a strategic approach to evidence generation is a comprehensive research strategy that will work for more than one year at all stages of product creation.

TAGGED:drug industrypharmaceutical companiespharmaceutical industry
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

2015 Trends for Rural Hospitals and Rural Healthcare

August 18, 2015

HIPAA Enforcement: Who’s in Charge?

February 3, 2014
eHealthHealth ReformMedical InnovationsMedical RecordsTechnology

Can Big Data Analytics Make Telemedicine More Functional?

December 13, 2017
covid vaccine
Covid-19Public Health

How Will the Supply Chain Support Vaccine Distribution?

February 20, 2021
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?